Innovations In Clinical Neuroscience

JAN-FEB 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 38 of 63

[ V O L U M E 1 4 , N U M B E R 1 – 2 , J A N U A R Y – F E B R U A R Y 2 0 1 7 ] Innovations in CLINICAL NEUROSCIENCE 39 2011;19:915–922. 46. Harvey PD, Loewenstein DA, Czaja SJ. Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia. Neurobiol Dis. 2013;53:18–25. 47. Ruse SA, Harvey PD, Davis VG, et al. Virtual reality functional capacity assessment in schizophrenia: preliminary data regarding feasibility and correlations with cognitive and functional capacity performance. Schizophr Res Cogn. 2014;1:21–26. 48. Atkins AS, Stroescu I, Spagnola NB, et al. Assessment of age-related differences in functional capacity using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT). J Prev Alzheimers Dis. 2015;2:121–127. 49. Kaye JA, Maxwell SA, Mattek N, et al. Intelligent systems for assessing aging changes: home-based, unobtrusive, and continuous assessment of aging. J Gerontol B Psychol Sci Soc. Sc 2011i. i180–i190. 50. Hayes TL, Abendroth F, Adami A, et al. Unobtrusive assessment of activity patterns associated with mild cognitive impairment. Alzheim Dement. 2008;4:395–405. 51. Dodge HH, Mattek NC, Austin D, et al. In-home walking speeds and variability trajectories associated with mild cognitive impairment. Neurology. 2012;78:1946–1952. 52. Hayes TL, Riley T, Mattek N, et al. Sleep habits in mild cognitive impairment. Alzheimer Dis Assoc Disord. 2014;28:145–150. 53. Petersen J, Austin D, Kaye JA, et al. Unobtrusive in-home detection of time spent out-of-home with applications to loneliness and physical activity. IEEE J Biomed Health Inform. 2014;18:1590– 1596. 54. Kaye J, Mattek N, Dodge HH, et al. Unobtrusive measurement of daily computer use to detect mild cognitive impairment. Alzheim Dement. 2014;10:10–17. 55. Hayes TL, Larimer N, Adami A, Kaye JA. Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health. 2009;. 56. Dodge HH, Kaye J, Zhu J, et al. Use of intra-individual distributions of daily acquired home-based measures increases RCT sensitivity. Alzheim Dement. 2014;10:P204. 57. Dodge HH, Zhu J, Mattek NC, et al. Use of high-frequency in-home monitoring data may reduce Sample sizes needed in clinical trials. PLoS ONE. 2015;10(9):e0138095. doi:10.1371/journal.pone.0138095 58. Fiske ST. Social cognition and social perception. Ann Rev Psychol. 1993;44:155–194. 59. Forbes CE, Grafman J. The role of the human prefrontal cortex in social cognition and moral judgment. Annu Rev Neurosc. 2010;33:299–324. 60. Cosentino S, Zahodne L, Brandt J. et al. Social cognition in Alzheimer's disease: a separate construct contributing to dependence. Alzheim Dement. 2014;10:818–826. 61. Cosentino S, Metcalfe J, Cary M, et al. Memory awareness influences everyday decision making capacity in Alzheimer's disease. Int J Alzheim Dis. 2011; Article ID 483897. 62. Karlawish JH, Casarett DJ, James BD, et al. The ability of persons with Alzheimer's disease (AD) to make a decision about taking an AD treatment. Neurology. 2005;64:1514–1519. 63. DeFeis B, Zhu C, Azar M, et al. The cost of disordered awareness: An examination of medicare use in dementia. Alzheim Dement. 2015;11:P597. 64. Baglio F, Castelli I, Alberoni M, et al. Theory of mind in amnestic mild cognitive impairment: an FMRI study. J Alzheim Dis. 2012;29:25–37. 65. Moreau N, Rauzy S, Bonnefoi B, et al. Different patterns of theory of mind impairment in mild cognitive impairment. J Alzheim Dis. 2015;45:581–59. 66. Poletti M, Bonuccelli U. Alteration of affective theory of mind in amnestic mild cognitive impairment. J Neuropsychol. 2013;7:121–131. 67. Pinkham AE, Penn DL, Green MF, et al. The Social Cognition Psychometric Evaluation (SCOPE) study: results of the expert survey and RAND panel. Schizophr Bull. 2014;40:813–823. 68. Miller LA, Hsieh S, Lah S, et al. One size does not fit all: face emotion processing impairments in semantic dementia, behavioural-variant frontotemporal dementia and Alzheimer's disease are mediated by distinct cognitive deficits. Behav Neuro. 2012;25:53–60. 69. Torralva T, Dorrego F, Sabe L, et al. Impairments of social cognition and decision making in Alzheimer's disease. Int Psychogeriatr. 2000;12:359–368. 70. Cavallo M, Enrici I, Adenzato M. The comprehension of social situations in a small group of patients with frontotemporal dementia and Alzheimer's disease. Acta Neuropsychologica. 2011;9:167–176. 71. Shany-Ur, T Poorzand P, Grossman SN, et al. Comprehension of insincere communication in neurodegenerative disease: lies, sarcasm, and theory of mind. Cortex. 2012;48:1329–1341. 72. Baron-Cohen S, Ring HA, Wheelwright S, et al. Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci. 1999;11:1891–1898. 73. Freedman M, Binns MA, Black SE, et al. Theory of mind and recognition of facial emotion in dementia: challenge to current concepts. Alzheimer Dis Assoc Disord. 2013 ;27(1):56-61. 74. Gregory C, Lough S, Stone V, et al. Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain. 2002;125:752–764. 75. Verdon CM, Fossati P, Verni M, et al. Social cognition: an early impairment in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord. 2007;21:25–30. 76. Cosentino S, Metcalfe J, Butterfield B, Stern Y. Objective metamemory testing captures awareness of deficit in Alzheimer's disease. Cortex. 2007;43:1004–1019. 77. Perrotin A, Belleville S, Isingrini M. Metamemory monitoring in mild cognitive impairment: evidence of a less accurate episodic feeling-of- knowing. Neuropsychologia. 2007;45:2811–2826. 78. Souchay C. Metamemory in Alzheimer's disease. Cortex. 2007;43:987–1003.

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - JAN-FEB 2017